We quantified COX5A, COX5B, and SOD2 protein levels in heart samples from patients with end-stage dilated cardiomyopathy (DCM) or subjects without obvious cardiovascular diseases, and observed that COX5A and SOD2 were clearly down-regulated in heart tissues with DCM (Figure 1). This evidence concerns the gene COX5A and familial dilated cardiomyopathy.